Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-067384
Filing Date
2021-12-01
Accepted
2021-12-01 20:35:32
Documents
1
Period of Report
2021-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11644
  Complete submission text file 0001209191-21-067384.txt   13053
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Issuer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11111 SANTA MONICA BLVD., SUITE 2000 LOS ANGELES CA 90025
Business Address
Zippelius Peter (Reporting) CIK: 0001775433 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36587 | Film No.: 211464624